BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 17455104)

  • 1. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
    Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
    J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
    Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
    Mühlbacher M; Konstantinidis A; Kasper S; Eichberger G; Hinterhuber H; Hofmann P; Nimmerrichter A; Schubert H; Egger C; Nickel M; Stuppaeck C
    Neuropsychobiology; 2006; 53(2):83-7. PubMed ID: 16511339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
    Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
    J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current evidence for aripiprazole as augmentation therapy in major depressive disorder.
    Khan A
    Expert Rev Neurother; 2008 Oct; 8(10):1435-47. PubMed ID: 18928339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive aripiprazole in treatment-resistant bipolar depression.
    Ketter TA; Wang PW; Chandler RA; Culver JL; Alarcon AM
    Ann Clin Psychiatry; 2006; 18(3):169-72. PubMed ID: 16923655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
    Thase ME; Bowden CL; Nashat M; Eudicone JM; Marcus R; McQuade RD; Carlson BX
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):121-31. PubMed ID: 22296512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase.
    Terevnikov V; Stenberg JH; Tiihonen J; Joffe M; Burkin M; Tchoukhine E; Joffe G
    Hum Psychopharmacol; 2011 Apr; 26(3):188-93. PubMed ID: 21469215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
    Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
    Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
    Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
    J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
    Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
    Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.
    Kemp DE; Gilmer WS; Fleck J; Straus JL; Dago PL; Karaffa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):574-7. PubMed ID: 17234318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.